JPML Won't Merge 12 Actions Over Plavix Injuries

Law360, New York (December 14, 2011, 8:07 PM ET) -- The U.S. Judicial Panel on Multidistrict Litigation on Wednesday refused to centralize 12 lawsuits against drugmakers Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC over injuries and deaths allegedly caused by anti-clotting drug Plavix.

The JPML agreed with Bristol-Myers and Sanofi-Aventis that the 12 lawsuits did involve some common factual issues involving the development, manufacture, regulatory approval, labeling and marketing of Plavix.

But the panel said the 10 actions pending in New Jersey federal court, filed in 2006 and 2007, were far more advanced than the remaining...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers